{
"id":"mk19_a_id_s12",
"subspecialtyId":"id",
"title":"Immunodeficiency Syndromes",
"jsonContent":{
"type":"section",
"id":"mk19_a_id_s12",
"title":{
"__html":"Immunodeficiency Syndromes"
},
"titleNode":{
"type":"section-title",
"hlId":"b18ad2",
"children":[
"Immunodeficiency Syndromes"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_id_s12_1",
"title":{
"__html":"Introduction"
},
"titleNode":{
"type":"section-title",
"hlId":"0b7979",
"children":[
"Introduction"
]
},
"children":[
{
"type":"p",
"hlId":"4aac2a",
"children":[
"Primary immunodeficiency disorders often present during childhood, but milder heritable forms may not manifest until adulthood. Primary immunodeficiency should be considered when patients have frequent infections or infections with unusual organisms. The specific microbiology is often a clue to which arm of the immune system is affected ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t35",
"wrapId":"1",
"children":[
"Table 35"
]
}
]
},
")"
]
},
". Diagnosis allows directed therapy, targeted immunization, and optimized empiric treatment of secondary infections."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_a_id_t35"
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s12_2",
"title":{
"__html":"Primary Immunodeficiencies"
},
"titleNode":{
"type":"section-title",
"hlId":"f9758b",
"children":[
"Primary Immunodeficiencies"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_id_s12_2_1",
"title":{
"__html":"Selective IgA Deficiency"
},
"titleNode":{
"type":"section-title",
"hlId":"e85cea",
"children":[
"Selective IgA Deficiency"
]
},
"children":[
{
"type":"p",
"hlId":"01b4e0",
"children":[
"Selective IgA deficiency (SIgAD) is the most common primary antibody deficiency, although most patients remain asymptomatic. IgA provides mucosal immunity; therefore, patients with SIgAD are susceptible to infections of the respiratory tract and, less frequently, gastrointestinal tract. Sinopulmonary infections are the most common presenting manifestation, particularly with encapsulated bacteria (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t35",
"wrapId":"2",
"children":[
"Table 35"
]
}
]
},
")"
]
},
". Anti-IgA IgE antibodies can rarely cause anaphylaxis to blood products; however, transfusions can be given with close monitoring."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_a_id_t35"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"d14fc2",
"children":[
"Patients with selective IgA deficiency may be asymptomatic, present with sinopulmonary or gastrointestinal tract infections, or rarely experience anaphylaxis to blood products."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s12_2_2",
"title":{
"__html":"Common Variable Immunodeficiency"
},
"titleNode":{
"type":"section-title",
"hlId":"a79535",
"children":[
"Common Variable Immunodeficiency"
]
},
"children":[
{
"type":"p",
"hlId":"7fc330",
"children":[
"Common variable immunodeficiency (CVID) is a heterogeneous syndrome associated with decreased quantitative immunoglobulin levels and impaired humoral response to antigens. The humoral response can be tested by measuring specific antibody production before and after immunization with tetanus and pneumococcal polysaccharide vaccines. Diagnosis is usually delayed until adolescence or adulthood, although a history of recurrent infection throughout childhood may often be elicited."
]
},
{
"type":"p",
"hlId":"ce3427",
"children":[
"CVID increases risk of upper and lower respiratory tract infections caused by encapsulated bacteria, ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Mycoplasma"
]
},
" species, and respiratory viruses. Gastrointestinal infections typically present with acute diarrhea caused by common enteropathogenic viruses or bacteria. Chronic diarrhea with malabsorption suggests giardiasis or chronic norovirus infection, an increasingly recognized pathogen in this population. Additionally, patients with CVID are at increased risk of autoimmune disease, inflammatory bowel disease, granulomatous disease (noncaseating granulomas in the lymphoid or solid organs), bronchiectasis, and malignancy."
]
},
{
"type":"p",
"hlId":"057c10",
"children":[
"Pooled immune globulin replacement therapy is performed through intravenous infusions or subcutaneous injections. Passive replacement is associated with lower rates of infections and hospitalizations. Immunization is only partially effective because of impaired vaccination response; live vaccines should be avoided. Prophylactic antibiotics are not typically indicated because they can predispose patients to infection with more resistant organisms."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"29706f",
"children":[
"Patients with common variable immunodeficiency can experience recurrent infections and are at increased risk of noninfectious complications, including autoimmune disease, inflammatory bowel disease, granulomatous disease, bronchiectasis, and malignancy."
]
},
{
"type":"keypoint",
"hlId":"13b726",
"children":[
"Live vaccines should be avoided in persons with common variable immunodeficiency."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s12_2_3",
"title":{
"__html":"Abnormalities in the Complement System"
},
"titleNode":{
"type":"section-title",
"hlId":"97d5ec",
"children":[
"Abnormalities in the Complement System"
]
},
"children":[
{
"type":"p",
"hlId":"b16727",
"children":[
"Infections and other antigenic stimuli trigger an inflammatory reaction through the classical, alternative, or lectin pathway of the complement cascade system. The result is formation of the membrane attack complex, which adheres to microbial pathogens to facilitate immune detection and destruction."
]
},
{
"type":"p",
"hlId":"5ee1b1",
"children":[
"Complement deficiencies can be divided into deficiencies in early or activating components (C2, C3, C4) and late or terminal components (C5-C9). Early component deficiency, especially C4, is associated with increased rates of systemic lupus erythematosus and increased risk of infection with encapsulated organisms. Patients with early complement deficiency present similarly to patients with CVID, with recurrent sinopulmonary infections. Terminal complement protein defects lead to an inability to form the membrane attack complex and typically present with recurrent infections of ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" species, particularly meningococcal meningitis. ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"N. meningitidis"
]
},
" infection in this population tends to be less severe than in immunocompetent persons, perhaps owing to uncommon serogroups. A personal or family history of recurrent ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infections is an indication to test the total hemolytic complement (CH",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"50"
]
},
") level because any defect in the classical complement pathway will result in a low total level."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"28c330",
"children":[
"Early component complement deficiency is associated with an increased rate of systemic lupus erythematosus and risk of infection with encapsulated organisms; terminal complement defects can result in recurrent ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infections."
]
},
{
"type":"keypoint",
"hlId":"386032",
"children":[
"Any defect in the classical complement pathway will result in low total hemolytic complement (CH",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"50"
]
},
") level."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s12_3",
"title":{
"__html":"Therapy-Induced Immunodeficiencies"
},
"titleNode":{
"type":"section-title",
"hlId":"afdef2",
"children":[
"Therapy-Induced Immunodeficiencies"
]
},
"children":[
{
"type":"p",
"hlId":"3afd9d",
"children":[
"Although diagnosis of primary immunodeficiencies is relatively rare in adults, secondary immunodeficiencies are quite common. ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t36",
"wrapId":"3",
"children":[
"Table 36"
]
}
]
},
" lists select medications causing secondary immunodeficiencies, related infections, and preventive measures."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_a_id_t36"
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s12_4",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Conigliaro P, Triggianese P, Ballanti E, et al. Complement, infection, and autoimmunity. Curr Opin Rheumatol. 2019;31:532-541. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31192812",
"target":"_blank"
},
"children":[
"PMID: 31192812"
]
},
" doi:10.1097/BOR.0000000000000633"
]
},
{
"type":"reference",
"children":[
"Odineal DD, Gershwin ME. The epidemiology and clinical manifestations of autoimmunity in selective IgA deficiency. Clin Rev Allergy Immunol. 2020;58:107-133. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31267472",
"target":"_blank"
},
"children":[
"PMID: 31267472"
]
},
" doi:10.1007/s12016-019-08756-7"
]
},
{
"type":"reference",
"children":[
"Sanges S, Wallet F, Blondiaux N, et al. Diagnosis of primary antibody and complement deficiencies in young adults after a first invasive bacterial infection. Clin Microbiol Infect. 2017;23:576.e1-576.e5. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28192236",
"target":"_blank"
},
"children":[
"PMID: 28192236"
]
},
" doi:10.1016/j.cmi.2017.02.005"
]
},
{
"type":"reference",
"children":[
"Yazdani R, Habibi S, Sharifi L, et al. Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management. J Investig Allergol Clin Immunol. 2020;30:14-34. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30741636",
"target":"_blank"
},
"children":[
"PMID: 30741636"
]
},
" doi:10.18176/jiaci.0388"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_a_id_t35":{
"id":"mk19_a_id_t35",
"number":35,
"bookId":"id",
"title":{
"__html":"Properties of Selected Primary Immunodeficiency Disorders"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"4440ff",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 35. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_id_t35"
}
]
},
"Properties of Selected Primary Immunodeficiency Disorders"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"col hd l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b1e1b5",
"class":"col hd l",
"children":[
"Common Infections and Pathogens"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"640bda",
"class":"col hd l",
"children":[
"Diagnostic Testing"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c4ac0",
"class":"col hd l",
"children":[
"Treatment"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0edaab",
"class":"cell txt l",
"children":[
"Selective IgA deficiency"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"342b86",
"class":"cell txt l",
"children":[
"Sinopulmonary infections:"
]
},
" ",
{
"type":"p",
"hlId":"3ca864",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Streptococcus pneumoniae"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"97e86b",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Haemophilus influenzae"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"bda3ba",
"class":"cell txt l",
"children":[
"Diarrhea/malabsorption:"
]
},
" ",
{
"type":"p",
"hlId":"6d6dda",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Giardia lamblia"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1467b1",
"class":"cell txt l",
"children":[
"IgA level <7 mg/dL (0.07 g/L) with normal IgG and IgM levels"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"096d1d",
"class":"cell txt l",
"children":[
"Vaccination against ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"S. pneumoniae"
]
}
]
},
" ",
{
"type":"p",
"hlId":"5ca76e",
"class":"cell txt l",
"children":[
"Most live vaccines are safe"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eebe9f",
"class":"cell txt l",
"children":[
"Common variable immunodeficiency"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"342b86",
"class":"cell txt l",
"children":[
"Sinopulmonary infections:"
]
},
" ",
{
"type":"p",
"hlId":"81d1c8",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"S. pneumoniae"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"3e3a93",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"H. influenzae"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"3e1e18",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Mycoplasma pneumoniae"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"6948a3",
"class":"cell txt l",
"children":[
"Respiratory viruses"
]
},
" ",
{
"type":"p",
"hlId":"f7f19d",
"class":"cell txt l",
"children":[
"Diarrhea:"
]
},
" ",
{
"type":"p",
"hlId":"9e0829",
"class":"cell txt li",
"children":[
"Norovirus"
]
},
" ",
{
"type":"p",
"hlId":"1b3013",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Campylobacter"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"3f130a",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"G. lamblia"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"ead2a4",
"class":"cell txt l",
"children":[
"Urethritis:"
]
},
" ",
{
"type":"p",
"hlId":"d30131",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Mycoplasma"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"d2a433",
"class":"cell txt li",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Ureaplasma"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"11e39f",
"class":"cell txt l",
"children":[
"IgG level and either IgA or IgM ≤2 standard deviations below the mean PLUS impaired humoral response to vaccination. Genetic testing may be used when antibody testing is nondiagnostic."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"58fcc4",
"class":"cell txt l",
"children":[
"Immune globulin replacement therapy"
]
},
" ",
{
"type":"p",
"hlId":"569ca5",
"class":"cell txt l",
"children":[
"Immunization with inactivated vaccines (live vaccines contraindicated)"
]
},
" ",
{
"type":"p",
"hlId":"77413b",
"class":"cell txt l",
"children":[
"Prophylactic antibiotics are not routinely indicated"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"78efad",
"class":"cell txt l",
"children":[
"Complement deficiency"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4b6057",
"class":"cell txt l",
"children":[
"Early components (C2-C4):"
]
},
" ",
{
"type":"p",
"hlId":"e70790",
"class":"cell txt l",
"children":[
"Similar to CVID"
]
},
" ",
{
"type":"p",
"hlId":"3fe16a",
"class":"cell txt l",
"children":[
"Late components (C5-C9):"
]
},
" ",
{
"type":"p",
"hlId":"3dde10",
"class":"cell txt l",
"children":[
"Recurrent infections with ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria gonorrhoeae"
]
},
" or ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria meningitidis"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"19a6ee",
"class":"cell txt l",
"children":[
"Decreased level of total hemolytic complement (CH",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"50"
]
},
")"
]
},
" ",
{
"type":"p",
"hlId":"45395b",
"class":"cell txt l",
"children":[
"Low or undetectable level of CH",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"50"
]
},
" or alternative pathway (AH",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"50"
]
},
") (factor B, factor D, or properdin)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fcc505",
"class":"cell txt l",
"children":[
"Same as CVID for C2-C4 complement deficiency"
]
},
" ",
{
"type":"p",
"hlId":"d9c9e9",
"class":"cell txt l",
"children":[
"May receive live vaccine"
]
},
" ",
{
"type":"p",
"hlId":"628f00",
"class":"cell txt l",
"children":[
"Quadrivalent meningococcal conjugate and serogroup B meningococcal vaccines for C5-C9 complement deficiency or properdin deficiency"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"CVID = common variable immunodeficiency."
]
]
},
"mk19_a_id_t36":{
"id":"mk19_a_id_t36",
"number":36,
"bookId":"id",
"title":{
"__html":"Select Medications Causing Secondary Immunodeficiency Disorders and Preventive Measures<sup>a</sup>"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"9b7279",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 36. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_id_t36"
}
]
},
"Select Medications Causing Secondary Immunodeficiency Disorders and Preventive Measures",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"353bd6",
"class":"col hd l",
"children":[
"Medication"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b1583",
"class":"col hd l",
"children":[
"Indication"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e8cda5",
"class":"col hd l",
"children":[
"Pathogens"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"90087c",
"class":"col hd l",
"children":[
"Prevention or Management"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"78727f",
"class":"cell txt l",
"children":[
"Tumor necrosis factor-α inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9573f9",
"class":"cell txt li",
"children":[
"Inflammatory bowel disease, inflammatory arthritis, psoriasis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eb67f8",
"class":"cell txt l",
"children":[
"Mycobacterial, fungal (",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Histoplasma"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Coccidioides"
]
},
"), reactivation of hepatitis B"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"75e52d",
"class":"cell txt l",
"children":[
"Screen for hepatitis B and C viruses before initiation; screen for tuberculosis before initiation and if a tuberculosis exposure occurs"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2449bd",
"class":"cell txt l",
"children":[
"Natalizumab"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e06f32",
"class":"cell txt li",
"children":[
"Multiple sclerosis, Crohn disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"119e9c",
"class":"cell txt l",
"children":[
"JC virus"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"869a3a",
"class":"cell txt l",
"children":[
"Screen for seropositivity at baseline, with repeat testing and brain MRI based on serostatus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"72a34b",
"class":"cell txt l",
"children":[
"Eculizumab",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e9fe32",
"class":"cell txt l",
"children":[
"Hemolytic uremic syndrome, paroxysmal nocturnal hemoglobinuria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9a1c02",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria meningitidis"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9d3566",
"class":"cell txt l",
"children":[
"Immunization with quadrivalent and serogroup B meningococcal vaccines 2 weeks before initiation, prophylactic penicillin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fad6a2",
"class":"cell txt l",
"children":[
"Rituximab"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ae531d",
"class":"cell txt l",
"children":[
"B-cell malignancies, autoimmune diseases"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"16696b",
"class":"cell txt l",
"children":[
"JC virus, reactivation of chronic hepatitis B, cytomegalovirus"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d4e054",
"class":"cell txt l",
"children":[
"Screen for hepatitis B with treatment of antigen-positive patients and consideration of treatment for previously infected antigen-negative patients"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"adb71f",
"class":"cell txt l",
"children":[
"Glucocorticoids"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"629daa",
"class":"cell txt l",
"children":[
"Multiple uses"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6f9a5",
"class":"cell txt l",
"children":[
"Hepatitis B, herpes zoster, ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Strongyloides"
]
},
" (reactivation); ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Pneumocystis jirovecii"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1a041d",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Pneumocystis"
]
},
" prophylaxis for patients with >1 month of glucocorticoid use at dose equivalent to >20 mg of prednisone"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" ",
{
"type":"cross-reference",
"target":"mk19_b_rm_s2",
"children":[
"MKSAP 19 Rheumatology"
]
},
" includes further information on some medications mentioned in this table."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Terminal complement inhibitor, conferring up to a 2000-fold increased risk of meningococcal disease."
]
]
}
}
}